| Literature DB >> 29125587 |
Abstract
Polyphenols are a group of plant metabolites with potent antioxidant properties, which protect against various chronic diseases induced by oxidative stress. Evidence showed that dietary polyphenols have emerged as one of the prominent scientific interests due to their role in the prevention of degenerative diseases in humans. Possible health beneficial effects of polyphenols are measured based on the human consumption and their bioavailability. Lentil (Lens culinaris; Family: Fabaceae) is a great source of polyphenol compounds with various health-promoting properties. Polyphenol-rich lentils have a potential effect on human health, possessing properties such as antioxidant, antidiabetic, anti-obesity, anti-hyperlipidemic, anti-inflammatory and anticancer. Based on the explorative study, the current comprehensive review aims to give up-to-date information on nutritive compositions, bioactive compounds and the health-promoting effect of polyphenol-rich lentils, which explores their therapeutic values for future clinical studies. All data of in vitro, in vivo and clinical studies of lentils and their impact on human health were collected from a library database and electronic search (Science Direct, PubMed and Google Scholar). Health-promoting information was gathered and orchestrated in the suitable place in the review.Entities:
Keywords: antioxidants; degenerative diseases; health-promoting effects; lentils; polyphenols
Mesh:
Substances:
Year: 2017 PMID: 29125587 PMCID: PMC5713359 DOI: 10.3390/ijms18112390
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Nutritional compositions of lentils in 100 g of the edible portion [7].
| Nutrients | Unit | Raw | Sprouted | Cooked |
|---|---|---|---|---|
| Water | g | 8.26–9.65 | 51.85–67.34 | 69.64–137.89 |
| Energy | kcal | 343–356 | 82–106 | 116–226 |
| Protein | g | 24.44–25.71 | 6.9–8.96 | 9.02–17.86 |
| Total lipid (fat) | g | 0.92–1.06 | 0.42–0.55 | 0.38–0.75 |
| Carbohydrate | g | 60–64.44 | 17.05–22.14 | 20.13–38.69 |
| Total dietary fiber | g | 10.7–31.4 | - | 7.9–15.6 |
| Total sugars | g | 2.03–2.86 | - | 1.80–3.56 |
| Calcium | mg | 35–57 | 19–25 | 19–38 |
| Iron | mg | 6.51–7.71 | 2.47–3.21 | 3.33–6.59 |
| Magnesium | mg | 47–69 | 28–37 | 36–71 |
| Phosphorus | mg | 281–335 | 133–173 | 180–356 |
| Potassium | mg | 677–943 | 248–322 | 369–731 |
| Sodium | mg | 3–6 | 8–11 | 123–471 |
| Zinc | mg | 3.27–5.89 | 1.16–1.51 | 1.27–2.51 |
| Vitamin C | mg | 3.4–4.5 | 12.7–16.5 | 1.5–3.0 |
| Thiamin | mg | 0.756–0.873 | 0.176–0.228 | 0.169–0.335 |
| Riboflavin | mg | 0.189–0.211 | 0.099–0.128 | 0.073–0.0145 |
| Niacin | mg | 2.605–3.459 | 0.869–1.128 | 1.060–2.099 |
| Vitamin B6 | mg | 0.540–0.698 | 0.146–0.190 | 0.178–0.352 |
| Folate | µg | 479–555 | 77–100 | 181–358 |
| Vitamin B12 | µg | 0.00 | 0.00 | 0.00 |
| Vitamin A, RAE | µg | 2.0–2.5 | 1.8–2.0 | 0 |
| Vitamin A, IU | IU | 32–39 | 35–45 | 8–16 |
| Vitamin E | mg | 0.49–0.55 | 0 | 0.11–0.22 |
| Vitamin K | µg | 4.2–5.0 | 0 | 1.7–3.4 |
| Total saturated fatty acids | g | 0.154–0.198 | 0.044–0.057 | 0.053–0.105 |
| Total monounsaturated fatty acids | g | 0.0179–0.193 | 0.08–0.104 | 0.064–0.127 |
| Total polyunsaturated fatty acids | g | 0.469–0.526 | 0.169–0.219 | 0.175–0.346 |
List of bioactive functional groups in lentils and their biological functions.
| Bioactive Functional Groups | Individual Components | Quantity in 100 g of Lentils | Biological Functions | Reference |
|---|---|---|---|---|
| Phytosterols | β-sitosterol | 15.0–24.0 mg | Regulate the membrane fluid | [ |
| campesterol | 15.0 mg | |||
| stigmasterol | 20.0 mg | |||
| Trypsin/protease inhibitors | Bowman–Birk trypsin inhibitors | 3–8 trypsin inhibitor unit (TIU)/mg | Anti-nutritional components; decrease the digestibility of dietary proteins; inhibit the cell proliferation in cancer | [ |
| Lectins | Lectins or hemagglutinins | 12.0 mg | Ability to agglutinate red blood cells RBC and strong stimulators of murine B lymphocyte proliferation | [ |
| Defensins | Defensins | 8.0 mg | Participate in the development of innate immunity | [ |
| Dietary Fibers | Fibers | Insoluble fibers (93–99.7 mg/g) and soluble fibers (<7 mg/g) | Potential effect of hypocholesterolemic, anti-cancer, anti-tumor, antibacterial and hypoglycemic effects | [ |
| Resistant starches | 25.4 g | Significant contributor to gastrointestinal health and gut microbiota | [ | |
| Polyphenols Flavonoids | Flavonols (e.g., quercetin and kaempferol) | 0.03 to 10.85 and 0.24 to 13.20 mg | Antioxidant potential | [ |
| Flavones, flavanones | Total phenolic content: 26 mg gallic acid equivalents (GAE/100 g fresh wt; total flavonoid content: 21 mg catechin equivalents/100 g, and the condensed tannin content of 870 mg catechin equivalents/100 g | Antioxidant activity and potential effect on cardiovascular disease (CVD), diabetes, osteoporosis and neurodegenerative diseases | [ | |
| Proanthocyanidins or condensed tannins (e.g., prodelphinidins and procyanidins) | ||||
| Flavan-3-ols or flavanols (e.g., catechin and gallocatechin) | 759 mg (GAE)/100 g; glycosides of flavanones: 33.1–186.0 µg; glycosides of flavonols: 9.6–241 µg; dimers procyanidins: 619–1122 µg; trimer procyanidins: 441–498 µg; tetramer procyanidins: 18.5–59.5 µg; galloylated procyanidins 69.3–123 µg | Antioxidant activity | [ | |
| Anthocyanidins (e.g., delphinidin and cyanidin) | ||||
| Polyphenols Non-flavonoids | Hydroxybenzoic acids | Hydroxybenzoic acids: 4.5–28.4 µg | Antioxidant activity and potential effect on diabetes, osteoporosis CVD and neurodegenerative diseases | [ |
| Hydroxycinnamic acids (e.g., | Prodelphinidins 369–725 µg; condensed tannins: 870 mg catechins equivalent | Antioxidant activity | [ | |
| Stilbenoids, trans-resveratrol-3- | Glycosides of trans-resveratrol: 5.5–9.3 µg; | Antioxidant activity and potential effect on diabetes and CVD | [ | |
| Phytoestrogens: isoflavones | Formononetin, daidzein, genistein, glycitein, matairesinol, biochanin A, coumestrol, lariciresinol, pinoresinol, secoisolariciresinol, coumestrol | Total isoflavones (9.5 μg), total lignans (26.6 μg) and total phytoestrogens (36.5 μg) | Antioxidant potential | [ |
| Phytate | Phytic acid | 620 mg | Inhibit the proliferation of colorectal cancer | [ |
| Triterpenoids | Squalene | 0.7 mg | Chemopreventive potential against colorectal cancer | [ |
| Saponins | Saponins | 25 mg | Hypoglycemic and antidiabetic potential | [ |
List of polyphenols in lentils (Lens culinaris) [30,31,32,33,34,35,36,37].
| Polyphenol | Classes | Sub-Classes | Compound Name | Structure |
|---|---|---|---|---|
| Flavonoids | Flavonoids | Flavanols | (−)-Epigallocatechin | |
| (+)-Catechin-3- | ||||
| Catechin | ||||
| Catechin-7- | ||||
| Catechin gallate | ||||
| Epicatechin | ||||
| Epicatechin gallate | ||||
| Flavonols | Quercetin-3- | |||
| Quercetin-3- | ||||
| Quercetin-3- | ||||
| Kaempferol-3- | ||||
| Kaempferol-4′- | ||||
| Kaempferol-5- | ||||
| Kaempferol-3- | ||||
| Kaempferol-3- | ||||
| Myricetin-3- | ||||
| 4″″-Acetylsagittatin A | ||||
| Proanthocyanidins | Procyanidin | |||
| Prodelphinidin | ||||
| Flavanones | Eriodictyol | |||
| Eriodictyol-7- | ||||
| Naringenin | ||||
| Flavone | Luteolin | |||
| Luteolin-4′- | ||||
| Luteolin-3′,7-diglucoside | ||||
| Luteolin-7- | ||||
| 5,7-dimethoxyflavone | ||||
| Anthocyanins | Malvidin-3- | |||
| Non-flavonoids | Phenolic acids | Hydroxybenzoic acids | Syringic acid | |
| Vanillic acid 4-|A-D-glucoside | ||||
| 2,3-Dihydroxy benzoic acid | ||||
| Gallic acid | ||||
| Hydroxycinnamic acid | 3-hydroxy cinnamic acid | |||
| Sinapic acid | ||||
| Other polyphenols | Hydroxycoumarin | 4-Hydroxy-6-methyl coumarin |
Summary of in vitro, in vivo and clinical studies on the antidiabetic activities of polyphenol-rich lentils.
| Polyphenol-Rich Lentils | Model | Dose and Route of Administration | Negative Control | Investigation | Results | Reference |
|---|---|---|---|---|---|---|
| Total phenolics and flavonoids | In vitro | 50–500 μg/mL | - | Assay of antioxidant activities DPPH, FRAP, ORAC and inhibitory properties against α-glucosidase and pancreatic lipase | Antidiabetic, hypotensive and antioxidant activity | [ |
| Total phenolics | In vitro | 100.9 mg/g f.m. | 300 mM NaCl | Assay of α-amylase inhibitor activity and expected glycemic index values | Antidiabetic potential | [ |
| Flavonoids | Male albino rats | 15 g/kg/p.o. of lentil food formulation | Alloxan (150 mg/kg bw | Assay of glucose, urea, serum total protein, total TG and TC | Antidiabetic and hypolipidemic potential | [ |
| Total phenolics and flavonoids | Male Nile rats | 720 g/kg/p.o. of lentil food formulation | STZ (35 mg/kg i.p.) | Assay of glycemic index, glycemic load and cumulative load, blood glucose (fasting, random and OGTT) and plasma lipid parameters (plasma TC and TG) plus necropsy findings (liver and kidney pathology plus adipose reserves) | Antidiabetic and hypolipidemic potential | [ |
| Flavonol glycosides and free flavanols | Male Sprague-Dawley rats | 57% raw whole lentil; 52% cooked whole lentil; 51% raw dehulled lentil; 47% cooked dehulled lentil/p.o. | STZ (35 mg/kg i.p.) | Assay of serum glucose and serum lipid levels | Antidiabetic and hypolipidemic potential | [ |
| Total phenols | Human with diabetes | 50 g cooked lentil/p.o. | - | Assay of FBS, TC and glycemic control | Antidiabetic and cardioprotective activity | [ |
| Total phenols | Human with diabetes | 1 cup cooked lentil/day/p.o. | - | Assay of body weight, HbA1C, TC, BP, heart rate, glycemic control | Antidiabetic and cardioprotective activity | [ |
| Total phenolics and flavonoids | Obese patients with type 2 diabetes | 60 g lentil sprouts/p.o. daily during 8 weeks | - | Assay of weight, height and waist circumference, lipid profile, | Antidiabetic and hypolipidemic potential | [ |
DPPH: 2,2-diphenyl-1-picrylhydrazyl; FRAP: ferric reducing antioxidant power assay; ORAC: oxygen radical absorbance capacity; g f.m.: germination fraction matter; p.o.: per oral; i.p.: intraperitoneal; bw: body weight; STZ: streptozotocin; OGTT: oral glucose tolerance test; TG: triglycerides; TC: total cholesterol; FBS: fasting blood sugar; BP: blood pressure; HbA1C: glycated hemoglobin.
Summary of in vitro, in vivo and clinical studies on the antioxidant activities of polyphenol-rich lentils.
| Polyphenol-Rich Lentils | Model | Dose and Route of Administration | Negative Control | Investigation | Results | Reference |
|---|---|---|---|---|---|---|
| Procyanidin and prodelphinidin dimers and trimers; gallate procyanidins; kaempferol derivatives, quercetin glucoside acetate; luteolin derivatives and | Human astrocytoma cell line (U-373), renal adenocarcinoma (TK-10), breast adenocarcinoma (MCF-7), melanoma (UACC-62), colon carcinoma (HT29) and hepatocellular carcinoma (HepG2) | 0.06–0.12 µg/µL | H2O2, FeSO4 and FeSO4 + H2O2 | Assay of antioxidant activity by ORAC, DPPH, MTT and intracellular ROS | Antioxidant neuroprotective and anticancer activities | [ |
| Flavanols and phenolic acids | Human colonic carcinoma cell line (Caco-2) | 20–100 μg/mL | - | Assay of proinflammatory cytokines COX-2, IL-1β and IL-6 in TNF-α | Anti-inflammatory activity | [ |
| Total phenolics and flavonoids | In vitro | 200 mg sprout extracts | - | Assay of radical activity and expected glycemic index values | Antioxidant and antidiabetic activity | [ |
| Flavonoids | In vitro | 100 μL, 1 mg/mL | - | Assay of TEAC, DPPH, superoxide radical, hydrogen peroxide, FRAP and inhibition of β-carotene degradation activity; diabetes was assayed on α-amylase and α-glucosidase activity | Antioxidant and antidiabetic potential | [ |
| Total phenolics and flavonoids | In vitro | 55–119 μg/mL | - | Assay of DPPH or ORAC, anti-inflammatory activities on LOX, COX-1, COX-2 pathways | Antioxidant and anti-inflammatory activities | [ |
| Total phenols, flavonoids and tannins | In vitro | - | - | Assay of DPPH | Antioxidant potential | [ |
| Total phenolics and flavonoids | In vitro | 25 and 40 μM | Arsenic (10, 25, and 40 μM | Assay of transcriptional upregulation of serine acetyltransferase, | Antioxidant potential | [ |
| Hydroxybenzoic compounds, protocatechuic, vanillic acid, aldehyde | In vitro | 0.02 and 0.1% of lentil seed extracts | - | Assay of hydroxyl radical scavenging activity | Antioxidant potential | [ |
| Kaempferol glucoside | In vitro | 0.00625–5 mg/mL | - | Assay of DPPH, TEAC, FRAP and ORAC | Antioxidant potential | [ |
| Total phenolics and flavonoids | In vitro | 0.00625–5 mg/mL | - | Assay of DPPH | Antioxidant potential | [ |
| Flavonol glycosides and free flavanols | In vitro | 100 mg | - | Assay of PRTC, TEAC, ABTS, total phenolics, tocopherols (α-T, β-T, γ-T, δ-T), GSH and L-ascorbic acid | Antioxidant potential | [ |
| Total phenolics and flavonoids | In vitro | 20–100 μg/mL | - | Assay of COX-2 producing PGE (2) inhibitory assay | Anti-inflammatory activity | [ |
MTT: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; ROS: reactive oxygen species; COX: cyclooxygenase; IL: interleukin; TNF: tumor necrosis factor; TEAC: trolox equivalent antioxidant capacity; LOX: lysyl oxidase; SOD: superoxide dismutase; GR: glutathione reductase; GST: glutathione s-transferase.
Summary of in vitro, in vivo, clinical and intervention/observational studies on the anti-obesity and cardioprotective potentials of polyphenol-rich lentils.
| Polyphenol-Rich Lentils | Model | Dose and Route of Administration | Negative Control | Investigation | Results | Reference |
|---|---|---|---|---|---|---|
| Flavonoids | Human colonic carcinoma cell line (Caco-2) | 1.5, 3, 4.5, 6, 7.5 and 10 mg/mL | - | Assay of LDH, caspase-3, total DNA fragmentation, morphological changes related to apoptosis | Chemo-preventive agents | [ |
| Free flavanols | Human with hyperhomocysteinemia and coronary artery disease | 500 μg folate and 10 g lentils and other pulses and foods/p.o. | - | Assay of plasma total homocysteine | Cardioprotective activity | [ |
| Phenolic acids | In vitro | 20–100 μg/mL | - | Assay of platelet aggregation activity | Cardioprotective activity | [ |
| Total phenolics | Male Wistar rats | 200 and 400 mg/kg/p.o. | Doxorubicin (15 mg/kg bw/i.p. | Assay of BUN, serum creatinine, serum total protein, urinary total protein, and urinary creatinine, SOD, CAT, LPO and GSH in kidney | Nephroprotective potential | [ |
| Phenolic compounds | Male albino rats | 100, 200, 400 mg/kg/p.o. | - | Assay of blood picture (RBC, WBC and Hb), lipid fraction (total lipid, TC, TG, HDL, LDL and VLDL), liver function (AST, ALT and ALP, bilirubin) and kidney function (uric acid, urea and creatinine), total protein and its fractions (albumin and globulin), lipid peroxidation and antioxidative enzyme activity (SOD, CAT) | Hypolipidemic and antihypercholesterolemic activity | [ |
| Total phenolics and flavonoids | Male Sprague-Dawley rats | Ten isocaloric and isonitrogenous diets were prepared; 5 of them were cholesterol-free and differed in the content of lentil powder (%): lentil-free (0), raw dehulled (60.5), raw whole (66.6), cooked dehulled (62.5) and cooked whole (65.6); while in the other 5, cholesterol (1%) | High cholesterol feed | Assay of TC, LDL-C, HDL-C, TG, AIP, CRR and atherogenic coefficient | Cardioprotective activity | [ |
| Total phenolics | Male Wistar rats | 200 g/kg/p.o. for 28 days | - | Assay of hepatic lipase and lipoprotein lipase in epididymal fat, gastrocnemius and heart | Cardioprotective and hypolipoproteinemia activity | [ |
| Flavonoids | Sprague-Dawley female rats | 100, 200, 400 mg/kg/p.o. | Triton WR-1339 (250 mg/kg/i.v.) | Assay of TC, TG, HDL, LDL and VLDL | Antihyperlipidemic activity | [ |
| Total phenolics | Human | - | - | Cross-cultural and intervention studies | Cardioprotective activity | [ |
| Phenolic acids | Human | 13% p.o. | - | Assay of LDL | Hypolipidemic activity | [ |
| Total phenolics | Human | 120–130 g cooked lentil/day for 30–56 days/p.o. | - | Assay of TC, LDL, TG | Hypolipidemic activity | [ |
| Phenolic acids | Human with hyperlipidemic patients | 140 g/oral for 4 months’ time | - | Assay of serum TC and TG | Hypolipidemic activity | [ |
LDH: lactate dehydrogenase; BUN: blood urea nitrogen; CAT: catalase; LPO: lipid peroxidation; WBC: white blood cells; Hb: hemoglobin; HDL: high density lipoprotein; LDL: low density lipoprotein; VLDL: very low density lipoprotein; AST: aspartate transaminase; ALT: alanine transaminase; ALP: alkaline phosphatase; AIP: atherogenic index of plasma; CRR: cardiac risk ratio; i.v.: intravenous.
Summary of the in vitro antimicrobial potentials of polyphenol-rich lentils.
| Polyphenol-Rich Lentils | Model | Dose and Route of Administration | Negative Control | Investigation | Results | Reference |
|---|---|---|---|---|---|---|
| Flavonoids and lectins | 0.1–1 mL | - | Assay of agar well diffusion method | Antibacterial activity | [ | |
| Flavonoids | 250 mg/mL | - | Assay of disc diffusion method | Antibacterial activity | [ | |
| Ellagic acid, lupeol and leucodelphinidin | 250 mg/mL | - | Assay of disc diffusion method | Antibacterial activity | [ | |
| Flavonoids and proteins | - | - | 47-residue, plant defensin was purified by ammonium sulfate precipitation, gel filtration, chromatography and RP-HPLC; complete amino acid sequence, RT-PCR, cloning and cDNA sequence were performed | Antifungal activity | [ | |
| Flavonoids and proteins | 36 µM | - | Mycelial growth in | Antifungal activity | [ | |
| Flavonoids, lentil lectin and the diterpene ester | Human peripheral blood mononuclear leucocytes. murine splenocytes and white Swiss inbred C67B1/6 mice | 600 µg/mL | Concanavalin A | Assay of interferon-γ production | Antiviral activity | [ |
pv.: pathovar; RP-HPLC: reverse phase high performance liquid chromatography.
Summary of in vitro, in vivo and clinical studies on the anticancer and chemopreventive effects of polyphenol-rich lentils.
| Polyphenol-Rich Lentils | Model | Dose and Route of Administration | Negative Control | Investigation | Results | Reference |
|---|---|---|---|---|---|---|
| Flavonoids, lentil lectins | Human colon adenocarcinoma HT29 and colonic fibroblast CCD-18Co cells | 19 µM | - | cDNA, encoding a Bowman–Birk protease inhibitor, assessed with an array of molecular masses | Antiproliferative properties in colon cancer | [ |
| Flavonoids, lentil lectins | Human colon carcinoma cell line CACO-2 | 1.5, 3, 4.5, 6, 7.5 and 10 mg/mL | - | Production of IL-1, IL-6, IL-8 and MCP-1 were measured by ELISA and RT-PCR | Anticancer activity | [ |
| Flavonoids, lentil lectins | Nasopharyngeal carcinoma CNE1 and CNE2 cell lines | 1–5 mg/mL | - | Assay of MTT, flow cytometry and Western blotting | Anticancer activity | [ |
| Total phenolics and flavonoids | In vitro | 100 µL | 2,2′-Azo | Assay of DPPH, radical scavenging assay, the hydroxyl radical- and the peroxyl radical-induced DNA strand scission assays | Potent chemopreventive agents | [ |
| Cooked Lentil seeds with iron | Sprague-Dawley rats | 35 mg/kg/p.o. | Iron-free diet (anemic group) | Assay of body weight, feed intake, Hb, hematocrit, MCV, MCH, MCHC, RBC, WBC and serum iron, platelet count and TIBC | Protective effect on iron deficiency anemia | [ |
| Kaempferol, quercetin and myricetin | Human | 1 cup cooked lentil/day/p.o. | - | Validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses’ Health Study II | Protective against breast cancer | [ |
| Flavonols | Human | 1 cup cooked lentil/day/p.o. | - | Validated food frequency questionnaires | Protective against breast cancer | [ |
| Total phenolics and flavonoids | Human | 1 cup cooked lentil/day/p.o. | - | Validated food frequency questionnaires in 1976 and 1982 from 78,000 men | Protective against prostate cancer | [ |
| Total phenolics and flavonoids | Human | 1 cup cooked lentil/day/p.o. | - | Validated food frequency questionnaires in 617 incident cases of prostate cancer | Protects against prostate cancer | [ |
| Isoflavones-genistein | Human | 1 cup cooked lentil/day/p.o. | - | A validated food frequency questionnaires incident cases of prostate cancer | Protects against prostate cancer | [ |
| Flavonols, flavones and flavonoid | Human | 1 cup cooked lentil/day/p.o. | - | A validated food frequency questionnaires | Protects against prostate cancer | [ |
| Flavonoids, lentil seed lectins | Human | - | - | Assay by using a flow cytometer | Screening for colorectal cancer | [ |
| Flavonoids, lentil seed lectins | Patients with benign thyroid disease and thyroid carcinomas | - | - | Assay of | Useful for distinguishing between thyroid carcinoma and benign thyroid tumor | [ |
| Flavonoids, lentil seed lectins | Patients with benign thyroid disease and thyroid carcinomas | - | - | Assay of | Useful prognostic marker for thyroid cancer | [ |
MCP: monocyte chemotactic protein; MCV: mean corpuscular value; MCH: mean corpuscular hemoglobin; MCHC: mean corpuscular hemoglobin concentration; TIBC: total iron binding capacity.